Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Utah
St. Jude Children's Research Hospital
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Blokhin's Russian Cancer Research Center
Albert Einstein College of Medicine
Children's Oncology Group
Technical University of Munich
Mayo Clinic
University of Miami
Children's Oncology Group
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)